DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
CAR-T - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'CAR-T - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and f...
January 2022
60 pages
Carcinoid Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Carcinoid Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Carcinoid Tumor - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Carcinoid Tumor - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Cardiac Amyloidosis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiac Amyloidosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Cardiac Arrythmia - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiac Arrythmia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Cardiac Insufficiency - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiac Insufficiency - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Cardiogenic Shock - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiogenic Shock - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Cardiorenal Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiorenal Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Cardiotoxicity - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiotoxicity - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Cardiovascular Calcification - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cardiovascular Calcification - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...
January 2022
60 pages
Carotid Artery Disease - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Carotid Artery Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Carpal Tunnel Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Carpal Tunnel Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Cartilage Diseases - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cartilage Diseases - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Cataplexy - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cataplexy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical a...
January 2022
60 pages
CD137 Agonist Antibody - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “CD137 Agonist Antibody - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipel...
January 2022
60 pages
CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
CD3 antigen inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “CD3 Antigen Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ pipel...
January 2022
60 pages
CD33 antigen inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “CD33 antigen inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pipeli...
January 2022
60 pages
CD47 antigen inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “CD47 antigen inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 28+ companies and...
January 2022
60 pages
CDK9 inhibitor - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 15+ com...
January 2022
60 pages
Celiac Disease (CD) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Celiac Disease (CD) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Cell Wall Synthesis Inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hrs “Cell Wall Synthesis Inhibitor - Pipeline Insight, 2022” report by DelveInsight offers comprehensive insights of the pipeline (under develop...
January 2022
90 pages
Cellulitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Cellulitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
